C. Neumann
- Dermatology top 2%
- Dermatology and Skin Diseases 4
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization 4
- Epidemiology top 10%
- Emergency Medicine top 10%
- Trauma and Emergency Care Studies 4
- Oncology top 10%
-
- Lipoproteins and Cardiovascular Health 10
-
- Blood Pressure and Hypertension Studies 6
-
- Pharmaceutical Economics and Policy 6
-
- Blood disorders and treatments 3
-
- Renal Diseases and Glomerulopathies 3
C. Neumann
46 papers receiving 996 citations
Peers
Comparison fields: 5 of 105
- Dermatology 216
- Immunology and Allergy 105
- Epidemiology 343
- Emergency Medicine 92
- Oncology 235
Countries citing papers authored by C. Neumann
This map shows the geographic impact of C. Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Neumann more than expected).
Fields of papers citing papers by C. Neumann
This network shows the impact of papers produced by C. Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Neumann. The network helps show where C. Neumann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Neumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 2 | |
| 2 | 2017 | 19 | |
| 3 | 2016 | 5 | |
| 4 | 2015 | 11 | |
| 5 | 2014 | 3 | |
| 6 | 2013 | 3 | |
| 7 | 2013 | 19 | |
| 8 | 2012 | 37 | |
| 9 | 2011 | 4 | |
| 10 | 2011 | 38 | |
| 11 | 2010 | 10 | |
| 12 | 2007 | 8 | |
| 13 | 2007 | 52 | |
| 14 | 2003 | 9 | |
| 15 | 2001 | 72 | |
| 16 | In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. | 2001 | 61 |
| 17 | 1997 | 18 | |
| 18 | 1996 | 234 | |
| 19 | 1992 | 126 | |
| 20 | 1973 | 1 |
About C. Neumann
C. Neumann is a scholar working on Dermatology, Immunology and Allergy, Nephrology, Physical Therapy, Sports Therapy and Rehabilitation and Emergency Medicine, having authored 46 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (10 papers), Blood Pressure and Hypertension Studies (6 papers), Pharmaceutical Economics and Policy (6 papers), Allergic Rhinitis and Sensitization (4 papers), Dermatology and Skin Diseases (4 papers), Trauma and Emergency Care Studies (4 papers), Blood disorders and treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Dermatology (216 citations), Immunology and Allergy (105 citations), Epidemiology (343 citations), Emergency Medicine (92 citations) and Oncology (235 citations). C. Neumann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Volker Schettler, H. zur Hausen, E. G. Jung, E.-M. de Villiers, Helmut H. Wolff, U.‐F. Haustein, H Hamm, Irene M. Leigh, M. Goos and Gerd Plewig. Their work appears in journals such as Atherosclerosis Supplements, Lung, Journal of Human Hypertension, Telemedicine Journal and e-Health and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.